Drug Side Effects

AZATHIOPRINE SODIUM

AZATHIOPRINE SODIUM was reported 2500 times

AZATHIOPRINE SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA STAGE IV 3 0.4286
1 SYNOVIAL FLUID ANALYSIS 16 0.1860
2 OSTEOSARCOMA RECURRENT 8 0.1333
3 PULMONARY VASCULITIS 68 0.1303
4 TOTAL LUNG CAPACITY ABNORMAL 43 0.1144
5 CAPILLARITIS 29 0.1094
6 MITE ALLERGY 53 0.0841
7 HODGKIN'S DISEASE STAGE II 2 0.0833
8 SPIROMETRY ABNORMAL 45 0.0776
9 COLOPATHY 4 0.0741
10 HEPATIC ENZYME 10 0.0725
11 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 41 0.0571
12 MYCOTIC ALLERGY 46 0.0553
13 ANOVULATORY CYCLE 11 0.0542
14 ONYCHOMADESIS 221 0.0539
15 ANTIPHOSPHOLIPID ANTIBODIES 10 0.0518
16 RHEUMATIC FEVER 223 0.0517
17 PSEUDOMONAS AERUGINOSA MENINGITIS 2 0.0513
18 ONYCHOMYCOSIS 218 0.0504
19 DUST ALLERGY 47 0.0494
20 FACET JOINT SYNDROME 150 0.0482
21 PERIUMBILICAL ABSCESS 3 0.0469
22 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 326 0.0465
23 FINGER DEFORMITY 220 0.0460
24 NEURITIS 69 0.0455
25 FLUCTUANCE 2 0.0426
26 PRODUCT LABEL CONFUSION 238 0.0414
27 PERIPHERAL VENOUS DISEASE 154 0.0391
28 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 73 0.0366
29 DRAIN SITE COMPLICATION 3 0.0361
30 GRIP STRENGTH DECREASED 307 0.0356
31 CONJUNCTIVITIS ALLERGIC 50 0.0346
32 RED BLOOD CELL SEDIMENTATION RATE DECREASED 9 0.0346
33 C-REACTIVE PROTEIN ABNORMAL 214 0.0338
34 DUODENAL ULCER PERFORATION 244 0.0337
35 ILEOCAECAL RESECTION 11 0.0335
36 HEPATOSPLENIC T-CELL LYMPHOMA 12 0.0326
37 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 3 0.0303
38 HAND DEFORMITY 385 0.0298
39 EYELID HAEMATOMA 2 0.0294
40 ACQUIRED PORPHYRIA 2 0.0286
41 HELICOBACTER INFECTION 286 0.0284
42 FOLLICULITIS 285 0.0280
43 NAIL DISORDER 239 0.0279
44 ENDOCARDITIS NONINFECTIVE 4 0.0274
45 TENOSYNOVITIS STENOSANS 15 0.0272
46 SYNOVIAL DISORDER 12 0.0267
47 PEMPHIGUS 326 0.0266
48 BREAST CANCER STAGE III 166 0.0261
49 COELIAC DISEASE 253 0.0261
50 NEONATAL HYPONATRAEMIA 3 0.0252
51 SWOLLEN JOINT COUNT 6 0.0247
52 RESPIRATORY SYMPTOM 67 0.0242
53 LUPUS VULGARIS 28 0.0238
54 LYMPHOCYTE COUNT 2 0.0235
55 RETINITIS 38 0.0231
56 CONGENITAL BLADDER ANOMALY 3 0.0229
57 DEEP VEIN THROMBOSIS POSTOPERATIVE 44 0.0227
58 BLEPHAROSPASM 139 0.0227
59 LIVE BIRTH 186 0.0226
60 BURSITIS 257 0.0216
61 GASTROINTESTINAL STOMA OUTPUT ABNORMAL 3 0.0211
62 HYPERCHOLESTEROLAEMIA 196 0.0207
63 MUSCLE INJURY 166 0.0205
64 HEPATIC ENZYME DECREASED 9 0.0204
65 BACK INJURY 217 0.0203
66 PERICARDITIS 328 0.0199
67 SYNOVITIS 353 0.0198
68 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 13 0.0197
69 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 35 0.0176
70 NORMOCHROMIC NORMOCYTIC ANAEMIA 52 0.0176
71 NAIL OPERATION 7 0.0172
72 LIP DRY 152 0.0172
73 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 9 0.0167
74 PROCTOCOLECTOMY 5 0.0167
75 WOUND INFECTION 178 0.0166
76 GLOSSODYNIA 365 0.0165
77 DISLOCATION OF VERTEBRA 36 0.0164
78 ANASTOMOTIC HAEMORRHAGE 3 0.0160
79 ADVERSE REACTION 206 0.0157
80 FORCED EXPIRATORY VOLUME DECREASED 44 0.0157
81 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 7 0.0153
82 SWOLLEN JOINT COUNT INCREASED 44 0.0143
83 ALLERGY TO CHEMICALS 17 0.0138
84 BONE EROSION 48 0.0137
85 JOINT RANGE OF MOTION DECREASED 180 0.0136
86 PRODUCT INTOLERANCE 3 0.0136
87 HYPOCHOLESTEROLAEMIA 4 0.0132
88 GRIP STRENGTH 3 0.0131
89 PULMONARY ALVEOLAR HAEMORRHAGE 72 0.0130
90 INTESTINAL ANASTOMOSIS 8 0.0129
91 PILONIDAL DISEASE 3 0.0128
92 EAR INFECTION VIRAL 2 0.0126
93 CARCINOID TUMOUR PULMONARY 3 0.0126
94 PREGNANCY INDUCED HYPERTENSION 2 0.0124
95 ORAL LICHEN PLANUS 6 0.0123
96 NEUROLOGICAL SYMPTOM 69 0.0123
97 POSTOPERATIVE ABSCESS 8 0.0121
98 WOUND 320 0.0117
99 CONTRAINDICATED PRODUCT ADMINISTERED 347 0.0117
100 WRIST DEFORMITY 7 0.0114
101 SMALL INTESTINAL STENOSIS 12 0.0114
102 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 2 0.0114
103 LIVER FUNCTION TEST INCREASED 239 0.0114
104 FOETAL MACROSOMIA 3 0.0112
105 PORPHYRIA ACUTE 15 0.0110
106 BILE DUCT STENOSIS 12 0.0101
107 NORMAL NEWBORN 54 0.0101
108 SERONEGATIVE ARTHRITIS 11 0.0099
109 OBESITY 156 0.0099
110 SYSTEMIC LUPUS ERYTHEMATOSUS 339 0.0097
111 SCLERITIS 15 0.0095
112 HEPATITIS 238 0.0094
113 JOB DISSATISFACTION 6 0.0094
114 FIBROMYALGIA 224 0.0093
115 BLOOD IRON ABNORMAL 9 0.0093
116 INTESTINAL FIBROSIS 2 0.0093
117 X-RAY ABNORMAL 16 0.0091
118 MUCOCUTANEOUS ULCERATION 2 0.0090
119 C-REACTIVE PROTEIN 8 0.0089
120 CONJUNCTIVITIS BACTERIAL 3 0.0089
121 C-REACTIVE PROTEIN INCREASED 319 0.0089
122 OVERLAP SYNDROME 6 0.0088
123 RHEUMATOID FACTOR POSITIVE 50 0.0088
124 RHEUMATOID NODULE 24 0.0087
125 DRUG-INDUCED LIVER INJURY 265 0.0087
126 CYTOMEGALOVIRUS ENTERITIS 3 0.0086
127 GASTROENTERITIS CLOSTRIDIAL 3 0.0086
128 TYPE 2 DIABETES MELLITUS 286 0.0086
129 IRRITABLE BOWEL SYNDROME 180 0.0085
130 BILIARY DILATATION 12 0.0082
131 KAPOSI'S SARCOMA 4 0.0080
132 VASCULITIS 89 0.0077
133 CONGENITAL ANOMALY 59 0.0077
134 ARTERIOSCLEROSIS CORONARY ARTERY 50 0.0077
135 MAMMOPLASTY 6 0.0076
136 POST PROCEDURAL DISCHARGE 5 0.0075
137 PALPABLE PURPURA 2 0.0074
138 LIVER INJURY 176 0.0074
139 DRUG TOLERANCE DECREASED 20 0.0072
140 TASTE DISORDER 143 0.0072
141 GAIT INABILITY 236 0.0072
142 THERAPEUTIC PRODUCT EFFECT DECREASED 316 0.0072
143 FULL BLOOD COUNT ABNORMAL 75 0.0072
144 TESTICULAR DISORDER 7 0.0070
145 ARTHROPATHY 378 0.0069
146 BLOOD CHOLESTEROL INCREASED 313 0.0068
147 SPONDYLOARTHROPATHY 4 0.0068
148 PSORIATIC ARTHROPATHY 269 0.0068
149 PROCTITIS ULCERATIVE 4 0.0067
150 HEPATIC ENZYME INCREASED 447 0.0067
151 DRUG LEVEL BELOW THERAPEUTIC 36 0.0066
152 OBSTRUCTIVE AIRWAYS DISORDER 69 0.0063
153 TENOSYNOVITIS 17 0.0062
154 INFLAMMATION 312 0.0062
155 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 39 0.0061
156 ASPARTATE AMINOTRANSFERASE ABNORMAL 9 0.0060
157 ILEECTOMY 2 0.0060
158 CUSHINGOID 19 0.0060
159 CHOLANGITIS SCLEROSING 12 0.0059
160 IMMUNE THROMBOCYTOPENIA 8 0.0059
161 FAECAL CALPROTECTIN INCREASED 18 0.0058
162 IMPAIRED HEALING 189 0.0058
163 ELBOW DEFORMITY 2 0.0058
164 ALLERGY TO ANIMAL 6 0.0058
165 EYE INJURY 17 0.0057
166 ANISOCORIA 2 0.0057
167 BRAIN MALFORMATION 2 0.0056
168 INFUSION RELATED REACTION 365 0.0056
169 ANTINUCLEAR ANTIBODY POSITIVE 18 0.0056
170 OSTEOARTHRITIS 231 0.0055
171 ARTERIOSCLEROSIS 51 0.0055
172 PLEURITIC PAIN 15 0.0055
173 NODULE 70 0.0054
174 EPILEPSY 163 0.0054
175 PULMONARY FIBROSIS 102 0.0054
176 CREPITATIONS 16 0.0054
177 NIGHT SWEATS 170 0.0053
178 INFUSION SITE BRUISING 11 0.0052
179 ILEOSTOMY 13 0.0052
180 CAMPYLOBACTER GASTROENTERITIS 3 0.0052
181 LUNG DISORDER 249 0.0052
182 NASAL DISCHARGE DISCOLOURATION 7 0.0051
183 PRINZMETAL ANGINA 5 0.0051
184 JC VIRUS INFECTION 8 0.0051
185 FAECAL CALPROTECTIN ABNORMAL 2 0.0050
186 AUTOIMMUNE DISORDER 47 0.0050
187 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 3 0.0049
188 GRANULOMA SKIN 4 0.0049
189 INFUSION SITE REACTION 14 0.0049
190 METASTASES TO SPLEEN 2 0.0049
191 DRUG INTOLERANCE 462 0.0049
192 WHEEZING 281 0.0048
193 DERMATOMYOSITIS 12 0.0048
194 EXOSTOSIS 43 0.0048
195 INTENTIONAL PRODUCT USE ISSUE 414 0.0048
196 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 76 0.0048
197 UTERINE DISORDER 11 0.0047
198 MOBILITY DECREASED 330 0.0047
199 FOOT DEFORMITY 51 0.0047
200 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 6 0.0046
201 LUPUS-LIKE SYNDROME 41 0.0046
202 MEIBOMIAN GLAND DYSFUNCTION 2 0.0046
203 INTRA-ABDOMINAL FLUID COLLECTION 8 0.0046
204 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 319 0.0046
205 DRUG LEVEL ABOVE THERAPEUTIC 20 0.0045
206 PULMONARY EOSINOPHILIA 2 0.0044
207 LARYNGITIS 47 0.0044
208 RED BLOOD CELL SEDIMENTATION RATE INCREASED 48 0.0044
209 SERUM SICKNESS 12 0.0044
210 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 10 0.0044
211 EAR MALFORMATION 2 0.0043
212 DISSEMINATED ASPERGILLOSIS 2 0.0043
213 INTESTINAL FISTULA 6 0.0043
214 RETINAL VEIN THROMBOSIS 3 0.0043
215 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 6 0.0043
216 HEPATIC CIRRHOSIS 78 0.0042
217 NEUROENDOCRINE CARCINOMA OF THE SKIN 4 0.0042
218 HODGKIN'S DISEASE 3 0.0041
219 LOWER RESPIRATORY TRACT INFECTION 184 0.0041
220 POST PROCEDURAL DIARRHOEA 2 0.0040
221 TREATMENT FAILURE 314 0.0039
222 INFECTED FISTULA 2 0.0038
223 LIMB DEFORMITY 6 0.0038
224 OCCULT BLOOD 2 0.0038
225 MUSCULOSKELETAL STIFFNESS 327 0.0038
226 CONGENITAL NOSE MALFORMATION 2 0.0038
227 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 4 0.0038
228 SYNOVIAL CYST 17 0.0037
229 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 170 0.0036
230 RHEUMATOID ARTHRITIS 404 0.0036
231 COLECTOMY TOTAL 2 0.0036
232 ANAL FISTULA 19 0.0036
233 LUNG INFECTION PSEUDOMONAL 2 0.0036
234 STRESS AT WORK 4 0.0036
235 STEROID DEPENDENCE 3 0.0036
236 STOMATITIS 214 0.0036
237 NECK PAIN 197 0.0036
238 POUCHITIS 3 0.0035
239 SWELLING 324 0.0035
240 NEONATAL RESPIRATORY DISTRESS 3 0.0035
241 EXPOSURE DURING PREGNANCY 215 0.0035
242 ENTEROCUTANEOUS FISTULA 3 0.0035
243 JOINT DISLOCATION 36 0.0035
244 GASTROINTESTINAL DISORDER 297 0.0034
245 ANAL ABSCESS 18 0.0034
246 SLEEP DISORDER 234 0.0034
247 INJECTION SITE REACTION 228 0.0034
248 GASTROOESOPHAGEAL REFLUX DISEASE 266 0.0034
249 BLISTER 184 0.0033
250 POLYDIPSIA 13 0.0033
251 MATERNAL EXPOSURE DURING PREGNANCY 288 0.0033
252 JOINT SWELLING 389 0.0033
253 PHARYNGEAL PARAESTHESIA 5 0.0032
254 PUSTULAR PSORIASIS 11 0.0032
255 GENERAL PHYSICAL HEALTH DETERIORATION 364 0.0032
256 CEREBELLAR SYNDROME 7 0.0032
257 ILL-DEFINED DISORDER 192 0.0032
258 INJURY 222 0.0032
259 RHEUMATOID LUNG 3 0.0032
260 ANTINUCLEAR ANTIBODY INCREASED 3 0.0031
261 DACTYLITIS 3 0.0031
262 PROTEIN TOTAL INCREASED 8 0.0031
263 NON-HODGKIN'S LYMPHOMA 4 0.0030
264 AORTITIS 2 0.0030
265 BLADDER NEOPLASM 5 0.0030
266 EXPOSURE TO SARS-COV-2 5 0.0029
267 HAEMOPTYSIS 81 0.0029
268 LYMPHADENITIS 7 0.0029
269 DYSPEPSIA 284 0.0029
270 BODY TEMPERATURE FLUCTUATION 6 0.0029
271 INTESTINAL STENOSIS 12 0.0029
272 GASTROINTESTINAL SCARRING 2 0.0029
273 MITRAL VALVE DISEASE 5 0.0028
274 ILEAL STENOSIS 5 0.0028
275 INCORRECT PRODUCT ADMINISTRATION DURATION 56 0.0028
276 JOINT EFFUSION 19 0.0028
277 FOOD INTOLERANCE 10 0.0028
278 DISSEMINATED CRYPTOCOCCOSIS 2 0.0028
279 SCIATICA 43 0.0027
280 PULMONARY TOXICITY 19 0.0027
281 DIZZINESS EXERTIONAL 2 0.0027
282 BLOOD PARATHYROID HORMONE DECREASED 4 0.0027
283 ULCER HAEMORRHAGE 18 0.0027
284 INFLAMMATORY BOWEL DISEASE 26 0.0027
285 MUSCULOSKELETAL PAIN 139 0.0027
286 BOWEL MOVEMENT IRREGULARITY 20 0.0027
287 ADRENOCORTICAL INSUFFICIENCY ACUTE 5 0.0026
288 BRONCHITIS BACTERIAL 2 0.0026
289 LICHEN PLANUS 6 0.0026
290 ABDOMINAL DISTENSION 270 0.0026
291 SMALL INTESTINAL RESECTION 3 0.0026
292 PREMATURE SEPARATION OF PLACENTA 4 0.0026
293 GASTROINTESTINAL TOXICITY 12 0.0026
294 GOUTY ARTHRITIS 2 0.0025
295 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
296 HYPOGLYCAEMIA NEONATAL 4 0.0025
297 PRESCRIBED OVERDOSE 48 0.0025
298 BREAST DISORDER 5 0.0025
299 WALKING AID USER 16 0.0024
300 RECTAL ABSCESS 4 0.0024
301 FISTULA DISCHARGE 3 0.0024
302 ABDOMINAL DISCOMFORT 390 0.0024
303 JOINT STIFFNESS 61 0.0024
304 FUNCTIONAL GASTROINTESTINAL DISORDER 8 0.0023
305 HYPOAESTHESIA 345 0.0023
306 CONDITION AGGRAVATED 695 0.0023
307 CROHN'S DISEASE 16 0.0023
308 ERYTHEMA NODOSUM 8 0.0023
309 ASPERGILLOSIS 3 0.0023
310 NASAL DISORDER 6 0.0023
311 DRUG LEVEL DECREASED 23 0.0023
312 HYPOTHYROIDISM 71 0.0023
313 APHTHOUS ULCER 17 0.0022
314 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
315 MIGRAINE WITH AURA 6 0.0022
316 SIALOADENITIS 3 0.0022
317 ALOPECIA 428 0.0022
318 MUSCLE SWELLING 2 0.0022
319 RESPIRATORY TRACT INFECTION VIRAL 5 0.0022
320 BRONCHIAL OBSTRUCTION 3 0.0022
321 HYPERSENSITIVITY 390 0.0021
322 PLACENTAL DISORDER 2 0.0021
323 OESOPHAGEAL STENOSIS 6 0.0021
324 DRY MOUTH 168 0.0021
325 MASTOIDITIS 2 0.0021
326 THERAPEUTIC REACTION TIME DECREASED 6 0.0021
327 DEFORMITY 19 0.0021
328 HYPERAEMIA 4 0.0020
329 COMPLEX REGIONAL PAIN SYNDROME 3 0.0020
330 MUSCULAR WEAKNESS 229 0.0020
331 TENDERNESS 21 0.0020
332 HAEMOGLOBIN INCREASED 9 0.0020
333 DRUG ERUPTION 35 0.0020
334 LIPASE INCREASED 15 0.0020
335 BREAST ABSCESS 2 0.0020
336 RUBBER SENSITIVITY 3 0.0020
337 FISTULA 22 0.0020
338 CONJUNCTIVAL OEDEMA 2 0.0020
339 HYPERTROPHIC CARDIOMYOPATHY 3 0.0020
340 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0020
341 COLITIS 73 0.0020
342 FREQUENT BOWEL MOVEMENTS 52 0.0020
343 HERNIA REPAIR 5 0.0020
344 SPONDYLITIS 7 0.0020
345 GENOTYPE DRUG RESISTANCE TEST POSITIVE 2 0.0020
346 GESTATIONAL DIABETES 9 0.0019
347 NON-ALCOHOLIC STEATOHEPATITIS 2 0.0019
348 MATERNAL EXPOSURE TIMING UNSPECIFIED 7 0.0019
349 AUTOIMMUNE HEPATITIS 13 0.0019
350 DRUG HYPERSENSITIVITY 358 0.0019
351 POOR VENOUS ACCESS 19 0.0019
352 PILOERECTION 2 0.0019
353 LOWER LIMB FRACTURE 35 0.0019
354 MIGRAINE 173 0.0018
355 TONSILLAR HYPERTROPHY 3 0.0018
356 MYOSITIS 16 0.0018
357 TONGUE ULCERATION 6 0.0018
358 PRESCRIBED UNDERDOSE 35 0.0018
359 PULMONARY GRANULOMA 2 0.0018
360 CONFUSIONAL STATE 280 0.0018
361 BLOOD AMYLASE INCREASED 3 0.0018
362 HAEMANGIOMA 4 0.0017
363 ACUTE PRERENAL FAILURE 2 0.0017
364 INCISION SITE PAIN 2 0.0017
365 EOSINOPHIL COUNT INCREASED 14 0.0017
366 GRANULOMATOSIS WITH POLYANGIITIS 2 0.0017
367 IMPAIRED WORK ABILITY 36 0.0017
368 PANNICULITIS 4 0.0017
369 EAR INFECTION 44 0.0017
370 HYPOXIA 58 0.0017
371 HYPERTENSION 349 0.0017
372 PRODUCTIVE COUGH 77 0.0016
373 INTERVERTEBRAL DISC OPERATION 2 0.0016
374 MUCOUS STOOLS 8 0.0016
375 ANAPHYLACTIC REACTION 89 0.0016
376 BLOOD PRESSURE FLUCTUATION 39 0.0016
377 FLANK PAIN 15 0.0016
378 HIP ARTHROPLASTY 24 0.0016
379 COLITIS ULCERATIVE 70 0.0016
380 CACHEXIA 8 0.0016
381 OESOPHAGEAL ULCER 6 0.0016
382 RALES 9 0.0016
383 BREAST CANCER STAGE II 13 0.0016
384 ATELECTASIS 15 0.0016
385 DRUG SPECIFIC ANTIBODY PRESENT 10 0.0016
386 ACTINIC KERATOSIS 4 0.0016
387 LARGE INTESTINAL STENOSIS 3 0.0015
388 ULCER 24 0.0015
389 SPINAL FUSION SURGERY 6 0.0015
390 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 25 0.0015
391 WEIGHT INCREASED 327 0.0015
392 PERIPHERAL SWELLING 225 0.0015
393 PREMENSTRUAL SYNDROME 2 0.0015
394 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 12 0.0015
395 BILIARY TRACT DISORDER 2 0.0015
396 LABELLED DRUG-DRUG INTERACTION ISSUE 2 0.0014
397 RENAL CELL CARCINOMA 7 0.0014
398 HEPATIC ENZYME ABNORMAL 7 0.0014
399 CHOLESTATIC LIVER INJURY 3 0.0014
400 DIVERTICULUM 10 0.0014
401 NASOPHARYNGITIS 255 0.0014
402 URTICARIA 228 0.0014
403 DISCOMFORT 83 0.0014
404 PRODUCT USE ISSUE 255 0.0014
405 UNDERDOSE 99 0.0014
406 RHINITIS ALLERGIC 6 0.0014
407 BLOOD LOSS ANAEMIA 3 0.0014
408 SMALL INTESTINE CARCINOMA 3 0.0013
409 ABNORMAL LOSS OF WEIGHT 9 0.0013
410 MENOPAUSAL SYMPTOMS 3 0.0013
411 ORAL PRURITUS 3 0.0013
412 DEFAECATION URGENCY 9 0.0013
413 ARTHRALGIA 534 0.0013
414 PARAESTHESIA 200 0.0013
415 PRE-ECLAMPSIA 6 0.0013
416 ASTHMA 141 0.0013
417 VARICELLA 3 0.0013
418 WEIGHT FLUCTUATION 13 0.0013
419 PROCTALGIA 8 0.0013
420 RASH VESICULAR 6 0.0013
421 OBSTRUCTION 3 0.0013
422 CRYPTOCOCCOSIS 2 0.0013
423 PAIN IN EXTREMITY 363 0.0012
424 DEAFNESS NEUROSENSORY 4 0.0012
425 BODY TEMPERATURE DECREASED 12 0.0012
426 PEPTIC ULCER 4 0.0012
427 MEMORY IMPAIRMENT 164 0.0012
428 ABSCESS 19 0.0012
429 OSTEITIS 3 0.0012
430 EROSIVE OESOPHAGITIS 2 0.0012
431 HEPATOTOXICITY 26 0.0012
432 ABSCESS LIMB 5 0.0012
433 INCREASED BRONCHIAL SECRETION 3 0.0012
434 PAPILLARY THYROID CANCER 2 0.0012
435 HEART RATE IRREGULAR 26 0.0012
436 APLASTIC ANAEMIA 6 0.0012
437 POLYMYOSITIS 2 0.0011
438 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
439 HYPERSENSITIVITY VASCULITIS 3 0.0011
440 EPSTEIN-BARR VIRUS INFECTION 7 0.0011
441 PYODERMA GANGRENOSUM 4 0.0011
442 PANCREATITIS 59 0.0011
443 PRODUCT USE IN UNAPPROVED INDICATION 272 0.0011
444 PAPILLOEDEMA 5 0.0011
445 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
446 OFF LABEL USE 931 0.0011
447 OXYGEN SATURATION ABNORMAL 3 0.0011
448 OSTEOPOROSIS 44 0.0011
449 UPPER RESPIRATORY TRACT INFECTION 49 0.0011
450 GENERAL SYMPTOM 8 0.0011
451 SNORING 4 0.0011
452 KNEE ARTHROPLASTY 22 0.0011
453 OCULAR HYPERTENSION 2 0.0011
454 INSOMNIA 278 0.0011
455 MUSCLE RUPTURE 4 0.0010
456 SKIN WARM 6 0.0010
457 MUSCLE SPASMS 189 0.0010
458 HYPERTRANSAMINASAEMIA 7 0.0010
459 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
460 CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0010
461 PRODUCT QUALITY ISSUE 136 0.0010
462 SKIN ULCER 26 0.0010
463 ROAD TRAFFIC ACCIDENT 42 0.0010
464 PNEUMONIA 322 0.0010
465 ANORECTAL DISORDER 2 0.0010
466 DYSLIPIDAEMIA 5 0.0010
467 DELIRIUM 34 0.0010
468 HEPATIC CYTOLYSIS 12 0.0010
469 CONJUNCTIVITIS 18 0.0010
470 THROMBOSIS 79 0.0010
471 RECTAL HAEMORRHAGE 42 0.0010
472 QUALITY OF LIFE DECREASED 13 0.0010
473 ARTHRITIS 76 0.0010
474 FOETAL DEATH 5 0.0010
475 HEART RATE DECREASED 34 0.0010
476 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 170 0.0010
477 SKIN NECROSIS 5 0.0010
478 SQUAMOUS CELL CARCINOMA 9 0.0010
479 LIVER DISORDER 42 0.0010
480 ENTERITIS 6 0.0010
481 LEUKOPENIA 47 0.0010
482 DEREALISATION 2 0.0009
483 ADVERSE EVENT 86 0.0009
484 HEPATIC NEOPLASM MALIGNANT 2 0.0009
485 MALAISE 408 0.0009
486 ABSCESS INTESTINAL 2 0.0009
487 RASH 401 0.0009
488 JAW FRACTURE 2 0.0009
489 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 3 0.0009
490 OTITIS MEDIA 3 0.0009
491 HAEMOLYSIS 7 0.0009
492 HEART RATE ABNORMAL 5 0.0009
493 INTRACRANIAL PRESSURE INCREASED 5 0.0009
494 COMPLICATIONS OF TRANSPLANTED KIDNEY 2 0.0009
495 COLECTOMY 5 0.0009
496 LICHENOID KERATOSIS 2 0.0009
497 PERONEAL NERVE PALSY 5 0.0009
498 THERAPY NON-RESPONDER 39 0.0009
499 HEPATOCELLULAR DAMAGE 2 0.0009
500 TRANSPLANT REJECTION 7 0.0009
501 HAEMATOCHEZIA 48 0.0009
502 DISABILITY 17 0.0009
503 PRODUCT PREPARATION ISSUE 5 0.0009
504 PHOTOPHOBIA 16 0.0009
505 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
506 ABDOMINAL PAIN UPPER 175 0.0009
507 BRONCHIOLITIS 3 0.0009
508 DECREASED APPETITE 194 0.0008
509 HEPATIC FUNCTION ABNORMAL 31 0.0008
510 RESPIRATORY DISORDER 25 0.0008
511 DERMAL CYST 2 0.0008
512 CHOLANGITIS 5 0.0008
513 BREATH SOUNDS ABNORMAL 4 0.0008
514 INJECTION SITE INFLAMMATION 4 0.0008
515 INFUSION SITE EXTRAVASATION 5 0.0008
516 INTESTINAL OBSTRUCTION 30 0.0008
517 BACK DISORDER 13 0.0008
518 BRAIN ABSCESS 2 0.0008
519 ABDOMINAL PAIN LOWER 20 0.0008
520 THERAPEUTIC RESPONSE SHORTENED 25 0.0008
521 FEELING JITTERY 15 0.0008
522 DISSEMINATED TUBERCULOSIS 2 0.0008
523 SKIN REACTION 11 0.0008
524 HEPATOSPLENOMEGALY 2 0.0008
525 FAECES HARD 3 0.0008
526 TONSILLITIS 4 0.0008
527 RASH MACULO-PAPULAR 17 0.0008
528 SERUM FERRITIN INCREASED 4 0.0008
529 DEPRESSION 173 0.0008
530 FALL 251 0.0008
531 BRONCHIECTASIS 5 0.0008
532 INTESTINAL RESECTION 4 0.0008
533 DIARRHOEA HAEMORRHAGIC 7 0.0008
534 RHINITIS 6 0.0008
535 UVEITIS 10 0.0008
536 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
537 ABNORMAL FAECES 6 0.0007
538 GASTROINTESTINAL PAIN 8 0.0007
539 CONTUSION 70 0.0007
540 HEADACHE 454 0.0007
541 MACULE 2 0.0007
542 LYMPHOPENIA 10 0.0007
543 BASAL CELL CARCINOMA 11 0.0007
544 RETINAL HAEMORRHAGE 5 0.0007
545 INTRAOCULAR PRESSURE INCREASED 9 0.0007
546 VITAMIN D DECREASED 6 0.0007
547 RED BLOOD CELL COUNT DECREASED 20 0.0007
548 OVARIAN CYST 7 0.0007
549 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
550 FIBULA FRACTURE 2 0.0007
551 FATIGUE 535 0.0007
552 PAIN 421 0.0007
553 ABDOMINAL PAIN 159 0.0007
554 ADVERSE DRUG REACTION 61 0.0007
555 ABORTION 2 0.0007
556 SINUSITIS 69 0.0007
557 WEIGHT DECREASED 187 0.0007
558 SQUAMOUS CELL CARCINOMA OF SKIN 4 0.0007
559 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
560 PREMATURE BABY 20 0.0007
561 PULMONARY EMBOLISM 63 0.0007
562 PERIPHERAL COLDNESS 9 0.0007
563 CONCUSSION 5 0.0007
564 PREGNANCY 13 0.0007
565 PROTEINURIA 12 0.0006
566 INFUSION SITE PAIN 8 0.0006
567 VISUAL IMPAIRMENT 77 0.0006
568 KIDNEY TRANSPLANT REJECTION 3 0.0006
569 MOUTH ULCERATION 13 0.0006
570 VOMITING 289 0.0006
571 SHOCK HAEMORRHAGIC 5 0.0006
572 PLATELET COUNT INCREASED 8 0.0006
573 EYE DISORDER 20 0.0006
574 JOINT INJURY 13 0.0006
575 DISEASE RECURRENCE 29 0.0006
576 FOETAL EXPOSURE DURING PREGNANCY 49 0.0006
577 OLIGOHYDRAMNIOS 2 0.0006
578 ASTHENIA 222 0.0006
579 SKIN LESION 16 0.0006
580 DYSPNOEA 331 0.0006
581 THYROID DISORDER 9 0.0006
582 DIZZINESS 290 0.0006
583 PYELONEPHRITIS 5 0.0006
584 MALABSORPTION 3 0.0006
585 DRUG INEFFECTIVE 759 0.0006
586 BRONCHOPNEUMONIA 2 0.0006
587 EAR PRURITUS 2 0.0006
588 OEDEMA 31 0.0006
589 BONE DENSITY DECREASED 18 0.0006
590 RESPIRATORY TRACT CONGESTION 9 0.0006
591 JAUNDICE CHOLESTATIC 2 0.0006
592 PREMATURE DELIVERY 9 0.0006
593 CUTANEOUS VASCULITIS 2 0.0006
594 GOUT 10 0.0006
595 PANCYTOPENIA 31 0.0006
596 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 31 0.0006
597 IMPAIRED QUALITY OF LIFE 8 0.0006
598 PHARYNGITIS STREPTOCOCCAL 6 0.0006
599 TIC 3 0.0006
600 THERAPEUTIC RESPONSE DECREASED 33 0.0006
601 ORAL DISORDER 4 0.0006
602 INTERVERTEBRAL DISC DEGENERATION 5 0.0005
603 TOOTH DISORDER 12 0.0005
604 NECROSIS 3 0.0005
605 OVERDOSE 115 0.0005
606 TOOTH INFECTION 7 0.0005
607 MOVEMENT DISORDER 17 0.0005
608 NEPHROLITHIASIS 24 0.0005
609 SARS-COV-2 TEST POSITIVE 7 0.0005
610 NAUSEA 411 0.0005
611 AMNESIA 34 0.0005
612 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
613 EAR PAIN 10 0.0005
614 BACTERAEMIA 6 0.0005
615 BLOOD ALBUMIN DECREASED 4 0.0005
616 HYPOMAGNESAEMIA 7 0.0005
617 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
618 BRONCHITIS 37 0.0005
619 INTERSTITIAL LUNG DISEASE 24 0.0005
620 PROTHROMBIN TIME PROLONGED 3 0.0005
621 PAIN IN JAW 14 0.0005
622 GASTRIC DISORDER 17 0.0005
623 NEUTROPHIL COUNT INCREASED 5 0.0005
624 PYREXIA 168 0.0005
625 DIARRHOEA 312 0.0005
626 HEPATIC STEATOSIS 9 0.0005
627 THERAPEUTIC RESPONSE CHANGED 3 0.0005
628 RASH PRURITIC 26 0.0005
629 NASAL CONGESTION 28 0.0005
630 HAEMODIALYSIS 4 0.0005
631 COLON CANCER 7 0.0005
632 OEDEMA PERIPHERAL 57 0.0005
633 MUSCULOSKELETAL DISCOMFORT 8 0.0005
634 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
635 MULTI-ORGAN FAILURE 8 0.0005
636 ABDOMINAL ABSCESS 2 0.0005
637 EYE PAIN 25 0.0005
638 FEEDING DISORDER 9 0.0005
639 MENINGITIS ASEPTIC 2 0.0005
640 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
641 MYOCARDITIS 5 0.0004
642 BODY TEMPERATURE INCREASED 9 0.0004
643 INFECTION 63 0.0004
644 DRY EYE 21 0.0004
645 LARGE INTESTINE POLYP 3 0.0004
646 EPISTAXIS 32 0.0004
647 DRUG EFFECT LESS THAN EXPECTED 6 0.0004
648 SEASONAL ALLERGY 6 0.0004
649 ABORTION INDUCED 4 0.0004
650 CYTOMEGALOVIRUS INFECTION 7 0.0004
651 HOSPITALISATION 64 0.0004
652 CHOLESTASIS 8 0.0004
653 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
654 HYPERTHYROIDISM 6 0.0004
655 GUILLAIN-BARRE SYNDROME 2 0.0004
656 THROMBOTIC MICROANGIOPATHY 4 0.0004
657 KIDNEY INFECTION 8 0.0004
658 INFLAMMATORY MARKER INCREASED 2 0.0004
659 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
660 RENAL TUBULAR NECROSIS 4 0.0004
661 HYPERCALCAEMIA 5 0.0004
662 HEPATOMEGALY 4 0.0004
663 ANXIETY 115 0.0004
664 PROTEIN URINE PRESENT 2 0.0004
665 PHARYNGITIS 5 0.0004
666 CHEST PAIN 74 0.0004
667 PERITONITIS BACTERIAL 4 0.0004
668 HYPERTHERMIA 3 0.0004
669 DRUG TOLERANCE 2 0.0004
670 FEELING HOT 24 0.0004
671 WHITE BLOOD CELL COUNT INCREASED 15 0.0004
672 DRUG RESISTANCE 10 0.0004
673 TUBERCULOSIS 5 0.0004
674 GASTROINTESTINAL INFLAMMATION 3 0.0004
675 OCULAR HYPERAEMIA 18 0.0004
676 AFFECTIVE DISORDER 3 0.0004
677 PULMONARY CONGESTION 5 0.0004
678 BLOOD PRESSURE INCREASED 57 0.0004
679 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
680 VIRAL INFECTION 12 0.0004
681 HEMIPLEGIA 3 0.0004
682 PANCREATITIS ACUTE 8 0.0004
683 PSEUDOMONAS INFECTION 3 0.0004
684 SWELLING FACE 23 0.0004
685 CHOLECYSTECTOMY 4 0.0004
686 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
687 BLOOD URIC ACID INCREASED 2 0.0004
688 COVID-19 61 0.0003
689 MEDICATION ERROR 19 0.0003
690 SPLENOMEGALY 4 0.0003
691 IMMUNODEFICIENCY 5 0.0003
692 LYMPHOCYTE COUNT DECREASED 6 0.0003
693 PURPURA 3 0.0003
694 TACHYCARDIA 30 0.0003
695 ANAL INCONTINENCE 3 0.0003
696 CHOLELITHIASIS 11 0.0003
697 JAUNDICE 9 0.0003
698 HEPATITIS CHOLESTATIC 2 0.0003
699 PELVIC PAIN 6 0.0003
700 OPTIC NEURITIS 3 0.0003
701 SMALL INTESTINAL OBSTRUCTION 4 0.0003
702 INFUSION SITE SWELLING 2 0.0003
703 BACTERIAL INFECTION 6 0.0003
704 MUSCLE SPASTICITY 4 0.0003
705 OLIGURIA 2 0.0003
706 PRURITUS 121 0.0003
707 SPUTUM DISCOLOURED 3 0.0003
708 TREATMENT NONCOMPLIANCE 17 0.0003
709 HYPOGAMMAGLOBULINAEMIA 2 0.0003
710 ERECTILE DYSFUNCTION 8 0.0003
711 HERPES SIMPLEX 2 0.0003
712 ASPERGILLUS INFECTION 2 0.0003
713 PSORIASIS 40 0.0003
714 LABORATORY TEST ABNORMAL 9 0.0003
715 EYE IRRITATION 17 0.0003
716 SINUS DISORDER 6 0.0003
717 SEPTIC SHOCK 13 0.0003
718 METASTASES TO LYMPH NODES 2 0.0003
719 MALIGNANT MELANOMA 4 0.0003
720 BREAST MASS 2 0.0003
721 FACE OEDEMA 5 0.0003
722 CHOLECYSTITIS CHRONIC 2 0.0003
723 NEPHROTIC SYNDROME 2 0.0003
724 LIMB DISCOMFORT 9 0.0003
725 SKIN EXFOLIATION 24 0.0003
726 PETECHIAE 3 0.0003
727 PAPULE 2 0.0003
728 BLOOD PRESSURE DECREASED 19 0.0003
729 METASTASES TO LIVER 5 0.0003
730 FLATULENCE 16 0.0003
731 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
732 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
733 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
734 MYELODYSPLASTIC SYNDROME 4 0.0003
735 TOOTH FRACTURE 3 0.0003
736 PSYCHIATRIC SYMPTOM 2 0.0003
737 AGRANULOCYTOSIS 5 0.0003
738 HYPERTENSIVE CRISIS 3 0.0003
739 HYDRONEPHROSIS 2 0.0003
740 DERMATITIS CONTACT 3 0.0003
741 BACK PAIN 61 0.0003
742 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
743 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
744 ACUTE MYELOID LEUKAEMIA 4 0.0003
745 PULMONARY HAEMORRHAGE 2 0.0003
746 GAIT DISTURBANCE 49 0.0003
747 CAESAREAN SECTION 3 0.0003
748 COVID-19 PNEUMONIA 3 0.0003
749 MACULAR DEGENERATION 3 0.0003
750 LOW BIRTH WEIGHT BABY 2 0.0003
751 HEAVY MENSTRUAL BLEEDING 2 0.0003
752 FEELING COLD 7 0.0003
753 STRESS 18 0.0003
754 BONE MARROW FAILURE 5 0.0002
755 ERYTHEMA 50 0.0002
756 NEOPLASM MALIGNANT 16 0.0002
757 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
758 ECZEMA 12 0.0002
759 BRAIN OEDEMA 3 0.0002
760 BLOOD UREA INCREASED 4 0.0002
761 COUGH 66 0.0002
762 ROTATOR CUFF SYNDROME 3 0.0002
763 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
764 BLOOD MAGNESIUM DECREASED 2 0.0002
765 MYOPATHY 2 0.0002
766 IMMUNOSUPPRESSION 2 0.0002
767 HIDRADENITIS 2 0.0002
768 NEUTROPENIA 31 0.0002
769 UNEVALUABLE EVENT 17 0.0002
770 MYALGIA 38 0.0002
771 NEUROPATHY PERIPHERAL 21 0.0002
772 FLUID RETENTION 11 0.0002
773 OROPHARYNGEAL PAIN 20 0.0002
774 APPENDICITIS 2 0.0002
775 INFLUENZA 24 0.0002
776 BREAST CANCER STAGE I 2 0.0002
777 INCREASED APPETITE 4 0.0002
778 FEELING ABNORMAL 51 0.0002
779 LIP SWELLING 7 0.0002
780 DEPRESSED MOOD 11 0.0002
781 ANGINA PECTORIS 6 0.0002
782 HERNIA 4 0.0002
783 GLAUCOMA 4 0.0002
784 LOCALISED INFECTION 5 0.0002
785 GASTROENTERITIS 3 0.0002
786 HAEMORRHOIDS 4 0.0002
787 CEREBRAL INFARCTION 5 0.0002
788 HAEMORRHAGE 21 0.0002
789 ABORTION SPONTANEOUS 8 0.0002
790 CELLULITIS 10 0.0002
791 LYMPHADENOPATHY 7 0.0002
792 SEPSIS 22 0.0002
793 DRY THROAT 2 0.0002
794 PRODUCT PRESCRIBING ISSUE 4 0.0002
795 CHEST DISCOMFORT 20 0.0002
796 HYPOKALAEMIA 9 0.0002
797 EAR DISCOMFORT 2 0.0002
798 DEVICE RELATED INFECTION 3 0.0002
799 RESPIRATORY TRACT INFECTION 5 0.0002
800 DEAFNESS 5 0.0002
801 INCONTINENCE 2 0.0002
802 ASPARTATE AMINOTRANSFERASE INCREASED 10 0.0002
803 CYSTITIS 6 0.0002
804 RHINORRHOEA 12 0.0002
805 CATARACT 11 0.0002
806 MUSCLE TIGHTNESS 3 0.0002
807 THROAT TIGHTNESS 5 0.0002
808 ASPIRATION 2 0.0002
809 OCULAR DISCOMFORT 2 0.0002
810 DRUG LEVEL INCREASED 3 0.0002
811 RESPIRATORY DISTRESS 5 0.0002
812 MALNUTRITION 2 0.0002
813 TRANSAMINASES INCREASED 4 0.0002
814 OXYGEN SATURATION DECREASED 10 0.0002
815 CIRCULATORY COLLAPSE 3 0.0002
816 MYOCARDIAL ISCHAEMIA 2 0.0002
817 ELECTROLYTE IMBALANCE 2 0.0002
818 HERPES ZOSTER 10 0.0002
819 HEART RATE INCREASED 17 0.0002
820 EYELID OEDEMA 2 0.0002
821 THROMBOCYTOPENIA 19 0.0002
822 CHILLS 20 0.0002
823 ASCITES 5 0.0002
824 CHOLECYSTITIS 2 0.0002
825 POLYNEUROPATHY 2 0.0002
826 GALLBLADDER DISORDER 3 0.0002
827 ADRENAL INSUFFICIENCY 2 0.0002
828 OSTEOMYELITIS 3 0.0002
829 GASTROENTERITIS VIRAL 3 0.0002
830 PRESYNCOPE 4 0.0002
831 HYPOTENSION 33 0.0002
832 CORONARY ARTERY DISEASE 5 0.0002
833 ALANINE AMINOTRANSFERASE INCREASED 10 0.0002
834 RENAL FAILURE ACUTE 7 0.0002
835 ILEUS 2 0.0002
836 CYST 2 0.0002
837 DERMATITIS ALLERGIC 2 0.0002
838 ILLNESS 16 0.0002
839 MUSCLE ATROPHY 2 0.0002
840 URINARY TRACT INFECTION 27 0.0002
841 INFLUENZA LIKE ILLNESS 13 0.0002
842 THROAT IRRITATION 7 0.0002
843 SURGERY 9 0.0002
844 ORAL CANDIDIASIS 2 0.0002
845 ANOREXIA 2 0.0002
846 IMMUNE SYSTEM DISORDER 2 0.0002
847 HAEMATOCRIT DECREASED 3 0.0002
848 HUNGER 2 0.0002
849 INCORRECT DOSE ADMINISTERED 33 0.0001
850 PERITONITIS 3 0.0001
851 DRUG TOXICITY 2 0.0001
852 DEVICE OCCLUSION 2 0.0001
853 TOOTH LOSS 3 0.0001
854 RASH MACULAR 5 0.0001
855 MASS 2 0.0001
856 CARPAL TUNNEL SYNDROME 2 0.0001
857 HEPATOCELLULAR INJURY 2 0.0001
858 APATHY 2 0.0001
859 LIVER FUNCTION TEST ABNORMAL 4 0.0001
860 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
861 CARDIOMYOPATHY 2 0.0001
862 STEVENS-JOHNSON SYNDROME 3 0.0001
863 HYPOAESTHESIA ORAL 2 0.0001
864 DRUG INTERACTION 21 0.0001
865 SHOCK 3 0.0001
866 VERTIGO 8 0.0001
867 DIABETES MELLITUS 10 0.0001
868 BLOOD COUNT ABNORMAL 2 0.0001
869 PLASMA CELL MYELOMA 5 0.0001
870 NERVOUS SYSTEM DISORDER 4 0.0001
871 BREAST CANCER 12 0.0001
872 DIABETIC KETOACIDOSIS 3 0.0001
873 ACUTE KIDNEY INJURY 19 0.0001
874 BLOOD POTASSIUM INCREASED 2 0.0001
875 DRUG DEPENDENCE 20 0.0001
876 BLINDNESS 5 0.0001
877 BLOOD CREATININE INCREASED 8 0.0001
878 PRODUCT COMPLAINT 3 0.0001
879 RHABDOMYOLYSIS 5 0.0001
880 HEMIPARESIS 2 0.0001
881 ANAPHYLACTIC SHOCK 3 0.0001
882 HAEMATURIA 4 0.0001
883 MENTAL DISORDER 5 0.0001
884 HYPERKALAEMIA 4 0.0001
885 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
886 DEHYDRATION 15 0.0001
887 DISTURBANCE IN ATTENTION 6 0.0001
888 MOOD ALTERED 3 0.0001
889 ANAEMIA 21 0.0001
890 BONE DISORDER 2 0.0001
891 DYSURIA 4 0.0001
892 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
893 DYSPNOEA EXERTIONAL 4 0.0001
894 RENAL FAILURE 14 0.0001
895 ACUTE RESPIRATORY FAILURE 2 0.0001
896 BALANCE DISORDER 9 0.0001
897 ORAL HERPES 2 0.0001
898 ATRIAL FIBRILLATION 10 0.0001
899 BLOOD PRESSURE ABNORMAL 2 0.0001
900 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
901 NEUTROPHIL COUNT DECREASED 4 0.0001
902 PLEURAL EFFUSION 6 0.0001
903 CONSTIPATION 21 0.0001
904 DERMATITIS 2 0.0001
905 CARDIAC DISORDER 9 0.0001
906 METABOLIC ACIDOSIS 3 0.0001
907 HIP FRACTURE 3 0.0001
908 ACNE 7 0.0001
909 EYE PRURITUS 3 0.0001
910 MELAENA 2 0.0001
911 STAPHYLOCOCCAL INFECTION 3 0.0001
912 OSTEONECROSIS 3 0.0001
913 SKIN DISORDER 3 0.0001
914 HYPONATRAEMIA 5 0.0001
915 LETHARGY 5 0.0001
916 TINNITUS 4 0.0001
917 NEOPLASM PROGRESSION 3 0.0001
918 PRODUCT DOSE OMISSION ISSUE 24 0.0001
919 COMA 4 0.0001
920 DEATH 72 0.0001
921 AGEUSIA 2 0.0001
922 HAEMATEMESIS 2 0.0001
923 FLUSHING 8 0.0001
924 HAEMATOMA 2 0.0001
925 DISEASE PROGRESSION 9 0.0001
926 NERVOUSNESS 4 0.0001
927 GASTRITIS 2 0.0001
928 MENSTRUATION IRREGULAR 2 0.0001
929 LIMB INJURY 2 0.0001
930 FEAR 2 0.0001
931 PALLOR 2 0.0001
932 DIVERTICULITIS 2 0.0001
933 PROCEDURAL PAIN 2 0.0001
934 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
935 NEEDLE ISSUE 2 0.0001
936 HYPERSOMNIA 2 0.0001
937 SOMNOLENCE 14 0.0001
938 PALPITATIONS 8 0.0001
939 BLOOD POTASSIUM DECREASED 2 0.0001
940 PLATELET COUNT DECREASED 7 0.0001
941 EMOTIONAL DISORDER 2 0.0001
942 RENAL DISORDER 3 0.0001
943 DYSPHAGIA 6 0.0001
944 HEAD INJURY 2 0.0001
945 ARRHYTHMIA 3 0.0001
946 MYOCARDIAL INFARCTION 11 0.0001
947 LOSS OF CONSCIOUSNESS 8 0.0001
948 HYPOGLYCAEMIA 3 0.0001
949 DRY SKIN 8 0.0001
950 INTENTIONAL PRODUCT MISUSE 5 0.0001
951 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
952 SPEECH DISORDER 3 0.0001
953 BURNING SENSATION 4 0.0001
954 RESPIRATORY FAILURE 4 0.0001
955 AGITATION 4 0.0001
956 DRUG EFFECT INCOMPLETE 2 0.0001
957 EYE SWELLING 2 0.0001
958 DYSARTHRIA 2 0.0001
959 CARDIAC FAILURE 4 0.0001
960 INJECTION SITE ERYTHEMA 6 0.0000
961 CARDIAC ARREST 4 0.0000
962 TREMOR 8 0.0000
963 TOXICITY TO VARIOUS AGENTS 8 0.0000
964 HYPOACUSIS 2 0.0000
965 DEEP VEIN THROMBOSIS 3 0.0000
966 ANGIOEDEMA 2 0.0000
967 VISION BLURRED 6 0.0000
968 MULTIPLE SCLEROSIS 2 0.0000
969 DERMATITIS ATOPIC 2 0.0000
970 SYNCOPE 4 0.0000
971 INJECTION SITE SWELLING 3 0.0000
972 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
973 DYSPHONIA 2 0.0000
974 NO ADVERSE EVENT 6 0.0000
975 INTENTIONAL OVERDOSE 2 0.0000
976 CEREBROVASCULAR ACCIDENT 5 0.0000
977 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
978 HOT FLUSH 2 0.0000
979 SEIZURE 3 0.0000
980 INJECTION SITE BRUISING 2 0.0000
981 CARDIAC FAILURE CONGESTIVE 2 0.0000
982 INJECTION SITE PAIN 7 0.0000
983 DRUG DOSE OMISSION 2 0.0000
984 BLOOD GLUCOSE INCREASED 2 0.0000